Suppr超能文献

[尿激肽释放酶与铅中毒风险]

[Urinary kallikrein and risk of lead poisoning].

作者信息

Iannaccone A, Porcelli G, Boscolo P

出版信息

Ann Ist Super Sanita. 1977;13(1-2):409-16.

PMID:603138
Abstract

Urinary kallikrein is an enzyme, probably originated in the kidney, which acts on plasma kininogen to produce kallidin, the decapeptide precursor of bradykinin, and appears to be implicated in various forms of arterial hypertension. It is significantly decreased in workers exposed to lead showing no hypertension or other clinical signs of lead poisoning. In respect to measurement of ALA or other heme precursors the determination of urinary kallikrein seems to be able to detect a different, and perhaps in certain cases earlier, effect of lead intoxication on enzyme functions.

摘要

尿激肽释放酶是一种可能起源于肾脏的酶,它作用于血浆激肽原产生缓激肽的十肽前体赖氨酰缓激肽,似乎与各种形式的动脉高血压有关。在未患高血压或无铅中毒其他临床症状的铅接触工人中,尿激肽释放酶显著降低。关于测定δ-氨基乙酰丙酸(ALA)或其他血红素前体,尿激肽释放酶的测定似乎能够检测到铅中毒对酶功能的不同影响,在某些情况下可能更早检测到这种影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验